← Back to headlines
Ionis Stock Falls After Arrowhead's Successful Drug Trial
Ionis Pharmaceuticals saw its stock drop following competitor Arrowhead Pharmaceuticals' announcement of a successful late-stage trial for its lipid-lowering drug.
22 Jul, 12:11 — 22 Jul, 12:11
Sources
Showing 1 of 1 sources
